SCHEMBL6355209

SCHEMBL6355209

CC(C)(C)[C@H](N)C(=O)O.Cc1ccc(S(=O)(=O)O)c(C)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.40
ATM Q13315 1/20 0.40
ALDH1A1 P00352 5/20 0.40
HPGD P15428 2/20 0.40
HSD17B10 Q99714 1/20 0.40
CASR P41180 1/20 0.40
MEP1B Q16820 1/20 0.40
LMNA P02545 2/20 0.39
MAPT P10636 2/20 0.38
GFER P55789 2/20 0.38
POLB P06746 1/20 0.38
ALOX12 P18054 1/20 0.38
HSD11B1 P28845 1/20 0.37
CYP2C19 P33261 1/20 0.36
ALKBH2 Q6NS38 1/20 0.36
ALKBH5 Q6P6C2 1/20 0.36
ALKBH3 Q96Q83 1/20 0.36
FTO Q9C0B1 1/20 0.36
KDM4E B2RXH2 2/20 0.36
F2 P00734 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Serine SCHEMBL9710978 0.81 CASR (0.47) L3MBTL1ATMALDH1A1HPGDHSD17B10
Serine SCHEMBL11133150 0.81 CASR (0.47) L3MBTL1ATMALDH1A1HPGDHSD17B10
SCHEMBL26645 0.80 MEP1B (0.49) L3MBTL1ATMALDH1A1HPGDHSD17B10
SCHEMBL29454656 0.80 MEP1B (0.49) L3MBTL1ATMALDH1A1HPGDHSD17B10
SCHEMBL6357306 0.80 CYP2D6 (0.47) L3MBTL1ALDH1A1LMNAMAPTKDM4E
Phenylglycine SCHEMBL11578499 0.80 L3MBTL1 (0.50) L3MBTL1ATMALDH1A1HPGDHSD17B10
SCHEMBL3105642 0.79 MEP1B (0.47) L3MBTL1ATMALDH1A1HPGDHSD17B10
Water SCHEMBL21412761 0.79 MEP1B (0.47) L3MBTL1ATMALDH1A1HPGDHSD17B10
SCHEMBL6908120 0.79 MEP1B (0.47) L3MBTL1ATMALDH1A1HPGDHSD17B10
Iodide SCHEMBL7708840 0.79 LMNA (0.47) L3MBTL1ATMALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050107473-A1 Process for producing tert-leucine AJINOMOTO CO. INC (JP) 2005-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107473-A1 Process for producing tert-leucine TERT, LRRK2, BCAT1 L3MBTL1 417/4885ATM 936/4885ALDH1A1 1392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.